Aims: Hydrogen sulfide (H2S) is a vasoactive gasotransmitter that is endogenously produced in the vasculature by the enzyme cystathionine γ-lyase (CSE). However, the importance of CSE activity and local H2S generation for ischemic vascular remodeling remains completely unknown. In this study, we examine the hypothesis that CSE critically regulates ischemic vascular remodeling involving H2S dependent mononuclear cell regulation of arteriogenesis. Methods and results: Arteriogenesis including mature vessel density, collateral formation; blood flow and SPY angiographic blush rate were determined in WT and CSEKO mice at different time points following femoral artery ligation (FAL). The role of endogenous H2S in regulation of IL-16 expression and subsequent recruitment of monocytes, and expression of VEGF and bFGF in ischemic tissues, were determined along with EPC (CD34/Flk1) formation and function. FAL of wild type mice significantly increased CSE activity, expression and endogenous H2S generation in ischemic tissues and monocyte infiltration, which was absent in CSEKO mice. Treatment of CSEKO mice with the polysulfide donor diallyl trisulfide (DATS) restored ischemic vascular remodeling, monocyte infiltration and cytokine expression. Importantly, exogenous H2S therapy restored NO bioavailability in CSEKO mice that was responsible for monocyte recruitment and arteriogenesis. Conclusion: Endogenous CSE/H2S regulates ischemic vascular remodeling mediated during hind limb ischemia through NO dependent monocyte recruitment and cytokine induction revealing a previously unknown mechanism of arteriogenesis.
Introduction
Hydrogen sulfide (H2S) is a gasotransmitter that has many positive cardiovascular effects. H2S has recently been identified as an endogenously produced gaseous signaling molecule. H2S is synthesized by cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfur transferase (3-MST) in peripheral vascular tissues. 1 CSE is recognized as the major enzyme that produces H2S with L-cysteine serving as the primary substrate. The CSE/H2S pathway mediates various physiological effects including angiogenesis, vasoregulation, neuromodulation, reducing oxidative stress, cytoprotection and cellular signaling. 2 H2S signaling is impaired during regeneration of vascular tissue following ischemia. 3 H2S has also both pro-inflammatory and anti-inflammatory properties, which are crucial for initiation and development of mature collaterals. 4 H2S promotes vascular smooth muscle relaxation and induces vasodilation of isolated blood vessels by opening K-ATP channels and induces angiogenesis by cross talk with nitric oxide (NO). 5, 6 Furthermore, studies have suggested that H2S is endogenously synthesized by monocytes and macrophages, which in turn regulates the functions of these cells that may play roles in arteriogenesis. 4 In addition, recently it was shown in a study that H2S induces EPC function and improves wound healing in type 2 diabetic mice. 7 Peripheral arterial disease (PAD) is a chronic occlusive disorder involving reduction of blood flow in the limbs that may lead to detrimental complications such as critical limb ischemia and limb amputation, and is associated with increased death due to involvement of other cardiovascular disorders. 8, 9 Additionally, patients with other cardiovascular disorders experience an increased prevalence of PAD. 10 Therapeutic angiogenesis is one of the better treatment options for PAD, but multiple clinical trials have shown limited benefits. 11 Neovascularization is a fundamental requirement for many pathophysiological conditions. 12 It occurs through three distinct processes that include vasculogenesis 13 , angiogenesis or arteriogenesis 3 via several intermediary-signaling molecules that enhance these processes. 14 The changes in mechanical forces acting on the endothelial cells lining the premature arteries stimulate the inflammatory signals needed for the start of the collateral growth. 15 Patients with both PAD and other co-morbid disorders suffer from impaired arteriogenesis due to dysfunction in inflammatory cell monocytes. 16 Cytokines such as IL-16 have been shown as a pro-arteriogenic factor in mouse hind limb ischemia. 17 Studies with human subjects have shown that impaired number and function of EPCs were observed in cardiovascular disease patients 18 including those with diabetes mellitus. 19 However, mobilization and recruitment of EPCs were observed during ischemia and inflammation to enhance vasculogenesis. 20 Ischemia can upregulate various other cytokines such as VEGF, SDF-1 and MCP-1 or interleukins that induce circulating EPCs and enhance revascularization. 21 Thus, H2S and mononuclear cell infiltrates might be important for arteriogenesis and angiogenesis under ischemic conditions. In the present study, CVR-2015-246 Vascular Biology
CSE regulation of ischemic vascular remodeling
Bone marrow and whole blood from the mice were collected and processed from ischemic and non-ischemic hind limb of WT and CSE KO mice to isolate monocytes using a protocol as described elsewhere with minor modifications. 25
Isolation of endothelial progenitor cells (EPCs):
EPCs were isolated from blood, bone marrow and skeletal muscles (ischemic and non-ischemic hind limbs) of WT, CSE KO mice (with or without DATS therapy) using protocols as described elsewhere with modifications. 26, 27 Measurement of cytokines expression IL-16, MCP-1, bFGF and VEGF levels were measured in gastrocnemius tissues using an ELISA kit from R&D Biosciences. Briefly, PBS or DATS treated mice were euthanized at days 3 and gastrocnemius muscle tissues harvested and protein lysates made. ELISA's were performed according to manufacturer's instructions.
Statistical analysis
Data were reported as mean ± standard error of the mean for all groups.
Statistical analysis was performed with Mann-Whitney or Kruskal-Wallis analysis of variance with Dunn's multiple-comparison tests. A p-value of <0.05 was required for statistical significance. Statistics were performed with GraphPad Prism 4.0 software.
Results:
H2S levels and CSE activity was increased in plasma and ischemic tissue Plasma free H2S was measured in WT and CSE KO mice and we found significant increases at day 3 and day 5 in WT mice but not in CSE KO mice (figure 1A). Free H2S levels in ischemic gastrocnemius muscle tissue were also significantly increased at days 5 and 7 in WT mice (figure 1B). Although there was no change in free H2S levels in plasma, a significant increase in free H2S levels in ischemic tissues was observed in CSE KO mice suggesting other compensatory pathways of H2S generation (CBS or 3-MST).
Importantly we observed a significant increase in CSE activity of plasma and muscle tissues at days 3 and 5 after ligation in WT mice, (supplementary figure 1A & B) , which was not observed in CSE KO mice. Increased CSE gene expression was also selectively observed in ischemic muscle tissues of WT but not in CSE KO (supplementary figure 1C & D) . These results indicate that CSE activity and gene expression are induced during chronic tissue ischemia.
( figure 1C) . Similarly, acute changes in tissue perfusion (blush rate) by SPY angiogram were significantly reduced in CSE KO mice compared to WT mice at days 3, 5 and 7 after ligation ( figure 1D ).
Formation of mature and functionally stable vessels is important for reperfusion of ischemic tissue. We next investigated the mature vessel density in WT and CSE KO mice by dual staining with anti CD31 and anti α-SMA antibodies. 3 We observed a significant decrease in mature vessel density and angiogenic indices (figure 1E and F) in CSE KO mice suggesting the importance of the role of CSE/H2S during arteriogenesis in ischemic tissue. Vessel densities were significantly increased in ischemic tissue vessel densities compared to nonischemic controls of WT and CSE KO (supplementary figure 2) . Representative images of blush rate and mature vessel density of WT and CSE KO mice are shown in supplementary figure 2A and B, respectively.
DATS therapy rescues arteriogenesis and ischemic limb blood flow in CSE KO mice
We next investigated the effect of exogenous H2S therapy using DATS. Parameters of arteriogenesis were closely examined since CSE/H2S appeared to significantly affect ischemic limb arteriogenesis activity. To understand the effect of DATS on ischemic blood flow recovery, we examined a range of DATS concentrations administered via retro-orbital injection (100, 200 and 500 µg/kg, twice daily) (supplementary figure 3A) . Hind-limb blood flow in ischemic tissue was dose dependently increased by DATS in WT mice with a median dose of 200 µg/kg. The pharmacokinetics of plasma free sulfide levels after injection of 200 µg/kg DATS is reported in supplementary figure 3B. Administration of DATS significantly restored ischemia blood flow in both WT and CSE KO mice ( figure  2A) . Similarly, blush rate detected by SPY angiogram was also augmented by DATS therapy both in WT and CSE KO mice (figure 2B).
Collateral arteriolar growth and remodeling are crucial during arteriogenesis. 28 We next examined the perfusion and diameter of the gracilis arteries in ischemic muscles with or without DATS therapy in WT and CSE KO mice. Figure 2C and D report that the diameter and number of perfused gracilis arteries were significantly less in CSE KO mice compared to WT mice, and were significantly increased after DATS therapy both in CSE KO and WT mice. Moreover, CD31 and α-SMA positive vessels were significantly increased after DATS therapy in ischemic tissue of CSE KO and WT mice (figure 2E and F).
Effect of CSE expression on EPCs and monocytes during ischemic hind limb ischemia
Bone marrow derived EPCs (BM-EPCs) in circulation and homed EPCs at the sites of ischemic event contribute to blood vessel formation. 29 Therefore, to determine cellular mechanisms of H2S/CSE on arteriogenesis, we examined EPCs and monocytes from the circulation, skeletal muscle tissue and the bone marrow from WT and CSE KO mice. There was a significant increase in BMderived and circulating EPCs in the ischemic limb by day 3, which was further elevated upon DATS treatment (supplementary figure 4A & B) . BM-derived EPCs increased in the circulation and the skeletal muscle by days 5 and 7 post-ligation in WT mice, especially with DATS treatment (supplementary figure 4C) . Induction of EPC's was significantly reduced in CSE KO mice (supplementary figure 4 D, E & F). Moreover, a moderate increase in CSE KO mouse EPC induction in bone marrow and blood was observed with DATS treatment, but no increase in skeletal muscle tissues.
Having observed a moderate effect of CSE/DATS on EPC function in ischemic tissue, we next examined whether monocyte recruitment was altered in CSE KO mice, as these cells critically regulate arteriogenesis. 30 Monocyte infiltration was increased in WT mice but significantly attenuated in CSE KO mice compared to WT ischemic tissue. Importantly, monocyte infiltration into ischemic tissue was increased with DATS therapy in WT mice and rescued in CSE KO mice ( figure 3) . Interestingly, ischemic tissue monocyte infiltration, CSE activity and H2S levels were significantly increased in circulating (supplementary figure  5A & B) and BM-derived monocytes (supplementary figure 5C & D) of WT mice at day 3 after femoral artery ligation compared to sham WT mice. However, these changes were not observed in monocyte populations isolated from CSE KO mice. Moreover, we observed that under hypoxia, expression of CSE though adenoviral-CSE induces monocyte mediated endothelial cell proliferation in coculture, while inhibition of CSE with specific CSE-shRNA inhibits this response (supplementary figure 5E ).
CSE regulates ischemia and inflammatory gene expression
Changes in mechanical forces after occlusion of the artery acts on endothelial cells lining the vascular walls and promotes the inflammatory signals required to start collateral formation. 31, 32 We first evaluated the expression of HIF-1α in skeletal muscle tissue, which was elevated under ischemia in WT but not CSE KO mice and with DATS treatment in both WT and CSE KO mice (supplementary figure 6A) . We next investigated the MCP-1 and IL-16 expression in ischemic tissues of WT and CSE KO mice at day 3 after femoral artery ligation as they participate in arteriogenesis. 17, 33 IL-16 levels were significantly increased in ischemic tissue of WT mice but not CSE KO mice; however, DATS therapy augmented IL-16 levels in both WT and CSE KO mice (supplementary figure 6B). No significant difference was observed in MCP-1 levels of CSE KO mice compared to WT mice (data not shown). These data indicate the role of CSE/H2S on IL-16 expression during ischemia, which modulates arteriogenesis via recruitment of monocytes.
Growth factors including VEGF and bFGF play significant roles during arteriogenesis and angiogenesis under ischemic conditions. 34 VEGF and bFGF expression were attenuated in ischemic limbs of CSE KO compared to WT mice, but were augmented upon DATS therapy in both WT and CSE KO mice (supplementary figure 6C and D) . Taken together, data here demonstrate that CSE/H2S increased IL-16, VEGF, and bFGF expression levels that are important for ischemic vascular remodeling.
CSE/H2S stimulates ischemic vascular remodeling and growth via NO dependent pathway
NO is a prime mediator of vascular remodeling in ischemic tissue. 35 Our previous work has shown that exogenous H2S stimulates ischemic revascularization in a NO/HIF-1 dependent pathway. 3 Based on these findings, we sought to quantify plasma and tissue levels of NO in WT and CSE KO mice with DATS treatment ( figure 4A and B) . We observed a significant decrease in total NOx levels of plasma and muscle tissues at pre ligation, days 3, 5 and 7 after ligation in CSE KO mice compared to WT mice. This indicates a role of CSE/H2S in modulating NO bioavailability that corroborates our earlier report. Importantly, this defect was recovered by DATS therapy in CSE KO mice, where a significant increase in NOx levels was observed in plasma and ligated muscle tissues ( figure 4C and D) .
We examined whether DATS therapy restored blood flow and revascularization in WT and CSE KO mice via NO. Either the eNOS inhibitor L-NAME or the NO scavenger cPTIO were used for these studies. Both L-NAME and cPTIO blunted DATS restoration of ischemic hind limb reperfusion in WT mice ( figure 5A & B) . However, L-NAME treatment with DATS in CSE KO mice did not attenuate ischemic limb reperfusion (figure 5C); while cPTIO treatment did significantly inhibit DATS mediated ischemic limb reperfusion in CSE KO mice ( Figure 5D ) indicating that the effects of DATS in CSE KO mice is dependent on NO signaling, but not dependent on eNOS activity. Supplementary figure 7 further reports the effect of these treatments on DATS vascular remodeling as determined by CD31 versus α-SMA staining. Inhibition of NO bioavailability via L-NAME or cPTIO significantly blunted tissue staining for these markers.
Nitrite therapy increases NO bioavailability, ischemic limb blood flow and vascular density in CSE KO ischemic tissues
Our laboratory has previously revealed that nitrite therapy selectively restores ischemic limb blood flow via its conversion back to NO that stimulates ischemic vascular remodeling. 24 Given the significant deficiency of NO bioavailability in CSE KO mice, we sought to examine whether ischemic vascular remodeling in these animals was primarily due to reduced NO. Thus, exogenous nitrite or control phosphate buffered saline was therapeutically administered to CSE KO mice with femoral artery ligation. We found in CSE KO mice that 165 μg/kg nitrite robustly stimulates ischemic vascular remodeling by augmenting blood flow (figure 6A) and vascular density and proliferation (figure 6B and C) in ischemic tissues. Importantly, these effects of nitrite on ischemic vascular remodeling and proliferation were significantly inhibited by the NO scavenger cPTIO (figure 6B and C).
Beneficial effects of nitrite and the inhibitory action by cPTIO were also observed with MAC-2 ischemic tissue staining for macrophages (figure 6D). We next examined whether the effect of macrophage recruitment was through a NO/IL-16 axis. We found that IL-16 levels were significantly increased in ischemic tissue of CSE KO with nitrite therapy, which was significantly reduced by cPTIO (figure 6E). Likewise, VEGF levels were significantly increased with nitrite therapy in CSE KO mice and inhibited by cPTIO cotreatment (figure 6F). These data clearly demonstrate that defective NO bioavailability is a primary mediator of defective ischemic vascular remodeling in CSE KO mice.
Discussion:
Studies from ours and other laboratories have shown that H2S augment blood perfusion under ischemic condition by stimulating vascular remodeling and angiogenesis. 3, 36, 37 However, the role of CSE and endogenous H2S generation and subsequent molecular mechanisms related to vasculogenesis and collateral growth and remodeling in mouse ischemic hind limb has not been elucidated. In the present study, we have made several novel findings as illustrated in figure 7 including: 1) CSE/H2S induces vasculogenesis through recruitment of EPCs and their homing to the site of ischemia, 2) arteriogenesis is impaired in ischemic tissue in the absence of CSE/H2S, which can be rescued by exogenous H2S therapy, 3) CSE/H2S rescues blood perfusion in ischemic tissue involving arteriogenesis via NO that is associated with differential monocyte recruitment and cytokine expression.
H2S regulates many endothelial functions and the metabolism of signaling molecules that stimulate angiogenesis and arteriogenesis under ischemic conditions. 36, 38, 39 Currently, several donors of H2S including DATS, Na2S and NaHS have been used in different experimental settings. 3, 40, 41 In this study, we have used DATS as a H2S donor to perform rescue experiments. Our previous study has shown that Na2S augments ischemic angiogenesis by stimulating reduction of nitrite to NO and subsequently potentiating the expression of HIF-1/VEGF in ischemic tissue. In the present study, DATS therapy significantly rescued the blood flow and blush rate of ischemic tissue of CSE KO and WT mice following ischemia induction. The number and diameter of mature arterial collaterals and CD31 positive vessel density was also augmented after DATS therapy following ischemia.
Monocyte recruitment at the injury site was also augmented by DATS therapy in CSE KO and WT mice following ischemia. Stimulation of the monocytic pathway also showed promising results for formation of collaterals after occlusion of main arteries. 42, 43 Studies from different laboratories have suggested that recruitment of monocytes and their transformation into macrophages in the site of injury is important during arteriogenesis. [42] [43] [44] Our data showed that monocyte recruitment was impaired during arteriogenesis in CSE KO mice, indicating that a functional CSE/H2S system facilitates monocyte recruitment for arteriole remodeling. We have also found that CSE activity and H2S generation in circulating and bone marrow derived monocytes following ischemia was significantly increased in WT mice. Together, it is clear that H2S plays a critical role in monocyte-mediated arteriogenesis and a lesser role for EPC-induced vasculogenesis in the murine femoral artery ligation model. Different cytokines and signaling molecules including nitric oxide are involved in initiation of arteriogenesis. 16, 24, 45 However, in this study, we have shown for the first time that CSE/H2S is important for stimulating arteriogenesis. Our data have shown that formation of collaterals and subsequent blood flow are significantly attenuated in CSE KO compared to WT mice. Direct stimulation of smooth muscle cells and endothelial cells is pivotal to initiate arteriogenesis. 15, 46 Our present study has demonstrated that collateral arterial density and microvascular vessel density were significantly less in CSE KO mice subjected to hind limb ischemia compared to WT mice highlighting the role of CSE/H2S for vascular remodeling.
We have recently reported that exogenous H2S therapy restores ischemic limb blood flow through angiogenesis mediated by nitrite/NO, suggesting a crosstalk between H2S and NO signaling pathways. 3 However, the role played by NOS/NO in H2S mediated vasculogenesis remains unknown. Results from L-NAME, cPTIO and VEGF-aptamer effects on blood flow indicate that H2S-mediated revascularization depends at least in part on increased bioavailability of NO under ischemic conditions in WT mice. Interestingly, DATS restores blood flow in CSE KO mice inhibited by L-NAME/VEGF-aptamer; while the effect of cPTIO inhibition on blood flow was only partially restored. This indicates that in CSE KO mice there is a limited role played by eNOS/VEGF but NO plays a prominent role, corroborating our previous findings. 3 Our study shows that NO levels decrease in CSE KO mice after ischemia induction indicating the role of NO in CSE/H2S mediated vascular remodeling. Nitric oxide serves dichotomous roles for vascular remodeling, which is also referred as the NO paradox. 47 At early stages of remodeling, NO stimulates recruitment of monocytes and expression of growth factors to promote vascular remodeling. 48 Our previous study revealed that H2S also participates in ischemic angiogenesis via an NO dependent pathway involving microvascular growth. 3 With this study, we have further discovered that nitrite stimulates IL-16 expression, recruits monocytes and increases VEGF expression in ischemic tissues of CSE KO mice indicating an important yet poorly understood relationship between sulfide bioavailability and NO metabolites. Further study is needed to better understand mechanistic relationships between sulfide and NO metabolite bioavailability and regulation of ischemic vascular remodeling.
In conclusion, the findings of the present study indicate that dysregulation or deficiency of CSE as well as H2S generation have a significant effect on vasculogenesis and collateral formation that leads to recovery of blood perfusion in the mouse ischemic hind limb. However, exogenous H2S therapy induces vasculogenesis by activating HIF-1 mediated VEGF signaling for EPC recruitment and also rescues impaired arteriogenesis and blood perfusion via the IL-16/monocyte recruitment/bFGF/VEGF signaling pathway. NO plays a critical role in this response suggesting that these two molecules coordinately regulate ischemic vascular remodeling and restoration of blood flow in the mouse hind limb. Thus, it is possible that H2S bioavailability and metabolism may be important in the setting of peripheral arterial disease or critical limb ischemia.
Significance
The role of endogenous hydrogen sulfide generation and bioavailability for ischemic vascular growth and remodeling has not been known. Our study provides critical new insight that increased endogenous cystathionine gamma lyase expression, activity, and hydrogen sulfide generation leading to augmentation of NO bioavailability is required for ischemic vascular remodeling that may be useful for future therapeutic revascularization approaches.
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Animals and experimental procedures
Twelve weeks old C57BL/6J (WT) and Cystathionine γ-lyase knock out (CSE KO) were used in this study. WT mice were purchased from the Jackson laboratory and CSE KO mice have been generated and are breeding in Dr. 
Induction of mouse hind limb ischemia upon femoral artery ligation
Permanent hind limb ischemia was induced in WT and CSEKO mice as previously described. 1, 2 Briefly, mice were anesthetized with an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (8 mg/kg). Aseptic surgery was performed by a linear incision in the left groin, and then the left common femoral artery was ligated distal to profunda femoris artery, cut, and excised to obtain a mouse model of severe hind limb ischemia. Immediate pallor was observed in the distal hind limb following ligation of the artery using 5-0 silk. Following surgery, the mice were randomly assigned to different experimental groups and treated for 3 weeks. Group profiles (n=8 unless otherwise stated): Control (PBS), or DATS (100, 200 and 500 µg) was administered retro-orbitally twice daily following the hind limb ischemia surgery until the end of the study.
Measurement of Cystathionine γ-lyase (CSE) activity
Tissues from the ischemic and non-ischemic hind limb of mice were collected at different time points of study. CSE activity (loss of cystathionine) was measured as previously described. 3 Briefly, tissue lysates were incubated with a mixture of 2mM cystathionine, 0.25 mM pyridoxal 5'-phosphate in 100 mM TrisHCl buffer (pH 8.3) for 60 min at 37°C. 10% Trichloroacitic acid was then added into the reaction mixture. After centrifugation of this mixture, the supernatant was mixed vigorously with 1% ninhydrin reagent and incubated for 2 minutes in boiling-water bath. The heated solution was then cooled down on ice for 2 minutes using a smartSpect Plus spectrophotometer (Bio-Rad). The activity of CSE was measured by cystathionine consumption and expressed as nanomoles of cystathionine utilized per mg of total protein per hour of incubation.
Measurement of hydrogen sulfide
Hydrogen sulfide was measured using monobromobimane by RP-HPLC as previously reported. 4 Briefly, mice were anesthetized with intraperitoneal (i.p) injection of ketamine/xylazine (100 and 8 mg/kg), blood and gastrocnemius skeletal muscle tissues were collected from WT and CSEKO mice at different time points following ischemia.
Measurement of free sulfide: Thirty μl of sample was treated with 70 µl of TrisHCl (pH 9.5, 0.1 mM DTPA), followed by 50 µl of MBB solution (10 mM) at 1% oxygen in a hypoxic chamber at room temperature and incubated for 30 minutes.
The reaction was terminated with 50 µl of stop solution (200 mM 5-sulfosalicylic acid). Lastly, SDB reaction product was measured using a Shimadzu
Prominence Ultra Fast HPLC system equipped with a fluorescence detector (λex 390 nm and λem 475 nm) coupled with an Eclipse XDB-C18 column (4.6 × 250 mm).
Measurement of acid-labile and bound sulfane sulfur pools:
Acid-labile sulfide was released by incubating samples in an acidic solution (pH 2.6, 100 mM phosphate buffer, 0.1 mM DTPA), in an enclosed system to contain volatilized hydrogen sulfide, then trapped in 100 mM Tris-HCl buffer (pH 9.5, 0.1 mM DTPA). The bound sulfane sulfur pool was measured by incubating the sample with 1 mM Tris (2-carboxyethyl) phosphine (TCEP) in 100 mM phosphate buffer at pH 2.6 with 0.1 mM DTPA, and sulfide measurement was performed in a manner analogous to that described above.
Acid-labile pool was determined by:
(Value obtained by the acid-liberation protocol) -(value from free hydrogen sulfide).
Bound sulfane sulfur pool was determined by:
(Value from TCEP plus acidic conditions) -(value from hydrogen sulfide measurement from the acid-liberation protocol alone)
Novadaq SPY Imaging Analysis
The SPY imaging was performed to quantify collateral formation as previously described. 2 Briefly, mice were anesthetized with inhaled isofluorane and the bolus injection of vascular contrast dye, indocyanine green (ICG, 30 μL, 165μM concentration) was administered retro-orbitally, and angiograms were recorded for one minute. Angiograms were taken before and after ligation of femoral artery as well as days 1, 3, 5, 7 post-ligation of either PBS or DATS treated animals. Collateral vessel numbers and diameters were measured using morphometric analysis tools in Nikon Elements software.
Immunohistochemical Staining of skeletal muscle tissues
Immunohistochemistry staining with anti-smooth muscle actin, anti-CD31
antibodies, CSE, HIF-1α, SDF was performed with nuclear stain DAPI (4′,6-Diamidine-2′-phenylindole dihydrochloride), as we have previously described. 2 Gastrocnemius muscle from ischemic and non-ischemic hind limbs of WT and CSEKO mice were dissected and embedded in OCT freezing medium, frozen, and cut into 5 µm sections. The slides were then fixed at −20°C in 95% ethanol/5% glacial acetic acid for 1 h. Slides were blocked with 5% horse serum 
Isolation of monocytes
Bone marrow and whole blood from the mice were collected and processed from ischemic and non-ischemic hind limb of WT and CSEKO mice to isolate monocytes using a protocol as described elsewhere with minor modifications. 5 Monocyte isolation was then performed using Easy Sep monocyte enrichment kits according to manufacturer manual instruction. Briefly, 
Isolation of endothelial progenitor cells (EPCs):
EPCs were isolated from blood, bone marrow and skeletal muscles of WT, CSEKO mice (with or without DATS therapy) using protocols as described elsewhere with modificationsa. EPCs from blood: Circulating endothelial progenitor cells (EPCs) in blood was isolated as described elsewhere. 6 Briefly, 1ml of blood was collected from the mice through retro orbital bleeding. Isolated blood was centrifuged under refrigeration (2-8°C) at 840 x g for 30 minutes. The middle yellow colored layer that includes mononuclear cells was collected and resuspended in FACS buffer for further analysis.
b. EPCs from bone marrow: EPCs will be cultured from mononuclear cells obtained from bone marrows of ischemic femurs as described elsewhere. 6 Briefly, bone marrow (BM) cells will be harvested by flushing the femurs of ischemic limbs from mice. Cells will be centrifuged and collected in media for further analysis.
c. EPCs from skeletal muscle: EPCs will be cultured from muscle tissues as described elsewhere. 7 Briefly, gastrocnemius muscle tissues will be excised, torn to small pieces and treated with collagenase II, Collagenase D and Dispase II with intermittent washing and centrifugation at 700 x g for 10 minutes.
Cells will be filtered through a 40μM cell strainer and cells are collected for further analysis.
To characterize and quantify the number of EPCs cells isolated from blood, skeletal muscle and bone marrow were labeled with Flk1-PE and CD34-FITC antibodies (BD biosciences) with corresponding isotype controls. Cells were then fixed in 1% paraformaldehyde to quantify further for flow cytometric analysis using FACS Calibur flow cytometer (BD biosciences). 
